The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis

OBJECTIVE: Long-acting β(2)-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) are burdened by the potential risk of inducing cardiovascular serious adverse events (SAEs) in COPD patients. Since the risk of combining a LABA with a LAMA could be greater, we have carried out a quantitativ...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Chron Obstruct Pulmon Dis
Asıl Yazarlar: Rogliani, Paola, Matera, Maria Gabriella, Ora, Josuel, Cazzola, Mario, Calzetta, Luigino
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2017
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5723113/
https://ncbi.nlm.nih.gov/pubmed/29255354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S146338
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller